Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Letter to the Editor

The Newfangled Upsurge of Double Mutant SARS-CoV-2 Virus in 2021-Current Scenario and Inspecting Ahead

Author(s): Sukhes Mukherjee* and Suman Kumar Ray

Volume 16, Issue 3, 2021

Page: [175 - 178] Pages: 4

DOI: 10.2174/2772434416666211124150255

Next »
[1]
Ray SK, Mukherjee S. Understanding the role of corona virus based on current scientific evidence - a review with emerging importance in pandemic. Rec Pat Antiinfect Drug Discov 2020; 15(2): 89-103.
[http://dx.doi.org/10.2174/1574891X15999200918144833] [PMID: 32957894]
[2]
Sanders RW, de Jong MD. Pandemic moves and countermoves: vaccines and viral variants. Lancet 2021; 397(10282): 1326-7.
[http://dx.doi.org/10.1016/S0140-6736(21)00730-3] [PMID: 33798497]
[3]
Weisblum Y, Schmidt F, Zhang F, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 2020; 9e61312
[http://dx.doi.org/10.7554/eLife.61312] [PMID: 33112236]
[4]
Wu J, Deng W, Li S, Yang X. Advances in research on ACE2 as a receptor for 2019-nCoV. Cell Mol Life Sci 2021; 78(2): 531-44.
[http://dx.doi.org/10.1007/s00018-020-03611-x] [PMID: 32780149]
[5]
Guruprasad L. Human SARS CoV-2 spike protein mutations. Proteins 2021; 89(5): 569-76.
[http://dx.doi.org/10.1002/prot.26042] [PMID: 33423311]
[6]
Krammer F. SARS-CoV-2 vaccines in development. Nature 2020; 586(7830): 516-27.
[http://dx.doi.org/10.1038/s41586-020-2798-3] [PMID: 32967006]
[7]
Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 2021; 19: 409-24.
[8]
Liu C, Zhou Q, Li Y, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 2020; 6(3): 315-31.
[http://dx.doi.org/10.1021/acscentsci.0c00272] [PMID: 32226821]
[9]
Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol 2021; 21(8): 475-84.
[http://dx.doi.org/10.1038/s41577-021-00578-z] [PMID: 34211186]
[10]
Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 2021; 21(4): 195-7.
[http://dx.doi.org/10.1038/s41577-021-00526-x] [PMID: 33674759]

© 2024 Bentham Science Publishers | Privacy Policy